A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.
Scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease.
'We think we can really accelerate the field and its capacity to improve lives'
Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
Paper identifies new combination of factors that allow scientists to grow stem cells in lab on much larger scale than previously possible
Medicine by Design-funded research could help answer fundamental biological questions and advance efforts to make organ-like structures
Researchers from Peter Zandstra's lab have developed new technologies that clear key barriers to developing a renewable source of cells for therapies.
